Insiders · Profile

PATTON JOHN STUART

Director at HALOZYME THERAPEUTICS · Chief Scientific Officer at NEKTAR THERAPEUTICS. Filing since 14 Mar 2007. CIK 0001247653

Company
Date
Role
Action
Shares
Amount
Of holding
19 Aug 2014
Director
Sold, plan not stated
75,000
$746.99K
29.4%
16 Sep 2013
Director
Sold, plan not stated
37,500
$343.68K
19.5%
13 Sep 2013
Director
Sold, plan not stated
37,500
$341.36K
16.3%
14 Nov 2008
Chief Scientific Officer
Sold, plan not stated
760
$3.32K
0.2%
16 Oct 2007
Director
Sold, plan not stated
15,000
$135.63K
50.0%
9 Oct 2007
Director
Sold, plan not stated
15,000
$130.31K
33.3%
2 Oct 2007
Director
Sold, plan not stated
15,000
$133.47K
25.0%
25 Sep 2007
Director
Sold, plan not stated
15,000
$134.10K
20.0%
18 Sep 2007
Director
Sold, plan not stated
17,471
$156.00K
18.9%
10 Jul 2007
Director
Sold, plan not stated
20,000
$195.67K
17.8%
26 Jun 2007
Director
Sold, plan not stated
20,000
$175.82K
15.1%
19 Jun 2007
Director
Sold, plan not stated
20,000
$205.07K
13.1%
12 Jun 2007
Director
Sold, plan not stated
20,000
$200.96K
11.6%
29 May 2007
Director
Sold, plan not stated
20,000
$205.32K
10.4%
23 May 2007
Director
Sold, plan not stated
15,000
$157.54K
7.2%
22 May 2007
Director
Sold, plan not stated
20,000
$211.13K
8.8%
18 Apr 2007
Director
Sold, plan not stated
25,000
$228.34K
10.5%
11 Apr 2007
Director
Sold, plan not stated
25,000
$215.39K
9.5%
4 Apr 2007
Director
Sold, plan not stated
25,000
$208.92K
8.7%
28 Mar 2007
Director
Sold, plan not stated
25,000
$209.98K
80.0%
21 Mar 2007
Director
Sold, plan not stated
25,000
$214.87K
7.4%
15 Mar 2007
Director
Sold, plan not stated
8,600
$68.80K
2.5%
14 Mar 2007
Director
Sold, plan not stated
16,400
$131.40K
4.5%
23 decisions on file.